Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101

CellinCells

Status: Enrolling

Conditions: Atrophic Scar

Study type: Observational

Funder types: Industry

Identifiers

NCT06435884

CIC101-01-LT

Details and patient eligibility

About

CIC101-01-LT is a long-term follow-up study of subjects treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.

Full description

The long-term safety of TRTP-101 was evaluated by participants in the CIC101-01 clinical trial and followed up for 5 years for serious adverse events.

Enrollment: 6 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Received TRTP-101 in clinical trial CIC101-01
• Provided written informed consent to participate in this study

Exclusion criteria

• Judged to be unsuitable to participate in this long-term follow-up